Caroline Dive: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
'''Caroline Dive''' is a | == Caroline Dive == | ||
[[File:Professor_Caroline_Dive.jpg|thumb|right|Professor Caroline Dive]] | |||
'''Caroline Dive''' is a prominent British scientist known for her contributions to the field of [[cancer research]]. She is a Professor of Pharmacology and the Deputy Director of the [[Cancer Research UK Manchester Institute]]. Her work primarily focuses on the study of [[circulating tumor cells]] (CTCs) and their role in [[metastasis]]. | |||
== Early Life and Education == | == Early Life and Education == | ||
Caroline Dive was born in | |||
Caroline Dive was born in the United Kingdom. She pursued her undergraduate studies in [[pharmacology]] at the [[University of London]], where she developed a keen interest in cancer biology. She later completed her PhD in [[biochemistry]] at the same institution, focusing on the mechanisms of [[apoptosis]] in cancer cells. | |||
== Career == | == Career == | ||
== Research | After completing her PhD, Dive joined the [[University of Manchester]] as a postdoctoral researcher. Her early work involved studying the molecular pathways involved in cancer cell death. She quickly rose through the academic ranks, becoming a lecturer and then a professor. | ||
Dive's research has significantly advanced the | |||
In 2003, Dive joined the Cancer Research UK Manchester Institute, where she established the Clinical and Experimental Pharmacology Group. Her research group is renowned for its pioneering work on circulating tumor cells, which are cancer cells that have shed from the primary tumor into the bloodstream. These cells are critical for understanding the process of metastasis and for developing new cancer therapies. | |||
== Research Contributions == | |||
Caroline Dive's research has significantly advanced the understanding of how cancer spreads and how it can be detected and treated. Her work on circulating tumor cells has led to the development of new diagnostic tools and therapeutic strategies. Dive's team has developed methods to isolate and analyze CTCs, providing insights into the genetic and phenotypic characteristics of metastatic cancer. | |||
== Awards and | Her research has also contributed to the development of personalized medicine approaches in oncology, allowing for more targeted and effective treatments for cancer patients. | ||
Dive | |||
== Awards and Honors == | |||
Caroline Dive has received numerous awards for her contributions to cancer research. She is a Fellow of the [[Academy of Medical Sciences]] and has been recognized by the [[Royal Society]] for her scientific achievements. Her work has been published in leading scientific journals, and she is a sought-after speaker at international conferences. | |||
== Related Pages == | |||
* [[Cancer Research UK]] | * [[Cancer Research UK]] | ||
* [[ | * [[Circulating Tumor Cells]] | ||
* [[ | * [[Metastasis]] | ||
* [[Pharmacology]] | |||
[[Category:Scientists]] | [[Category:British Scientists]] | ||
[[Category:Cancer Researchers]] | [[Category:Cancer Researchers]] | ||
[[Category: | [[Category:Women in Science]] | ||
Latest revision as of 11:47, 15 February 2025
Caroline Dive[edit]
Caroline Dive is a prominent British scientist known for her contributions to the field of cancer research. She is a Professor of Pharmacology and the Deputy Director of the Cancer Research UK Manchester Institute. Her work primarily focuses on the study of circulating tumor cells (CTCs) and their role in metastasis.
Early Life and Education[edit]
Caroline Dive was born in the United Kingdom. She pursued her undergraduate studies in pharmacology at the University of London, where she developed a keen interest in cancer biology. She later completed her PhD in biochemistry at the same institution, focusing on the mechanisms of apoptosis in cancer cells.
Career[edit]
After completing her PhD, Dive joined the University of Manchester as a postdoctoral researcher. Her early work involved studying the molecular pathways involved in cancer cell death. She quickly rose through the academic ranks, becoming a lecturer and then a professor.
In 2003, Dive joined the Cancer Research UK Manchester Institute, where she established the Clinical and Experimental Pharmacology Group. Her research group is renowned for its pioneering work on circulating tumor cells, which are cancer cells that have shed from the primary tumor into the bloodstream. These cells are critical for understanding the process of metastasis and for developing new cancer therapies.
Research Contributions[edit]
Caroline Dive's research has significantly advanced the understanding of how cancer spreads and how it can be detected and treated. Her work on circulating tumor cells has led to the development of new diagnostic tools and therapeutic strategies. Dive's team has developed methods to isolate and analyze CTCs, providing insights into the genetic and phenotypic characteristics of metastatic cancer.
Her research has also contributed to the development of personalized medicine approaches in oncology, allowing for more targeted and effective treatments for cancer patients.
Awards and Honors[edit]
Caroline Dive has received numerous awards for her contributions to cancer research. She is a Fellow of the Academy of Medical Sciences and has been recognized by the Royal Society for her scientific achievements. Her work has been published in leading scientific journals, and she is a sought-after speaker at international conferences.
